Hypnosis & Hypnotherapy, Revisited.

blog: Reframing and Reprograming with Hypnotherapy Explore our blog for the latest insights and tips on hypnotherapy, well-being, and personal growth…

By Luis Miguel Gallardo, Certified Hypnotherapist8 min read1,857 words

Explore our blog for the latest insights and tips on hypnotherapy, well-being, and personal growth.

Learn from experts and stay informed about the newest trends and research in the field.

  • The Science Behind Hypnotherapy: Understanding how hypnotherapy works and its benefits.
  • Coaching, NLP, Mindfulness and Hypnotherapy: How combining these practices can enhance your well-being.
  • Success Stories: Real-life stories of how hypnotherapy has helped individuals achieve their goals.

Hypnosis & Hypnotherapy, Revisited.

January 19, 2026|Acceptance, Addiction, Anger, Anxiety, Behavior Therapy, Bullying, Childhood, Coaching, CognitiveBehavioralTherapy, Compassion, Compassionate Inquiry, Conditions, Conscious Parenting, Consciousness, COVID-19, Depression, Emotional Awareness, Flourishing, Forgiveness, Freedom, Gestalt, Grief, Happiness, HealingThroughHypnosis, Healthy Eating, Hypnosis Misconceptions, Hypnotherapy, InterpersonalHypnotherapy, Isolation, LBL, Life Between Lives, Limitation, Love, Motivation, NLP, Online Hypnotherapy, Pain, Paralysis, Past Life Regressions, Peace, Phobias, Psychoanalysis, Psychobiology, Public Speaking, Regression, Self-Confidence, Self-Esteem, Sleep, Stress, Success Stories, Trauma, Unmet Needs, Vulnerability, Wisdom, Yoga

Hypnosis & Hypnotherapy, Revisited: What the Evidence (2018–2026) Really Shows

For many people, the word hypnosis still brings up stage shows, swinging watches, and the fear of “losing control.” But the scientific story has changed—dramatically.

In my recent paper, “Hypnosis and Hypnotherapy: A Comprehensive Review of Therapeutic Impact, Neurobiological Mechanisms, and Evidence-Based Outcomes (2018–2026)” (January 2026), I synthesize the modern research on hypnosis as a clinical tool: what it helps with, what’s happening in the brain during hypnosis, how strong the outcomes are, and what the field needs next.

This blog post is the accessible, human version of that review—no jargon required.

First: What hypnosis is (and what hypnotherapy means)

In the paper, I define hypnosis as a state of focused attention, heightened suggestibility, and increased responsiveness to therapeutic suggestions. Hypnotherapy is simply the clinical application of hypnosis to support healing—often as a structured intervention delivered by a trained practitioner.

Two important clarifications:

  • Hypnosis isn’t “mind control.”
  • Hypnotherapy isn’t an alternative to medicine in the “either/or” sense—it’s increasingly supported as a non‑pharmacological, evidence-based option that can be used alone or alongside standard care.

Why the 2018–2026 period matters

The last several years have seen an acceleration in hypnosis research—more rigorous randomized controlled trials, more sophisticated brain imaging, and larger evidence syntheses (meta-analyses). This is one reason hypnosis has become harder to dismiss as “just placebo” and easier to evaluate as a real clinical intervention.

The big picture: What the evidence says (in plain language)

Here are the headline findings from the review:

  • Across conditions, evidence syntheses report effect sizes that often land in the medium-to-large range, with reported values stretching from small/near-zero in some contexts to very large in others.
  • A major “meta-analysis of meta-analyses” (49 meta-analyses covering 261 primary studies) concluded hypnosis can positively impact both mental and somatic health, with a meaningful portion of effects falling into medium and large ranges.
  • Hypnotherapy has especially strong evidence for areas like pain, medical procedures, depression, anxiety, and perioperative care.
  • Clinical trials suggest hypnotherapy can achieve outcomes comparable to CBT in depression, with long-term follow-ups extending years, not just weeks.
  • Safety data across the studies reviewed is striking: no significant adverse events were reported in association with hypnotic interventions in the reviewed body of research (with appropriate professional delivery and screening).

But a serious review must also be honest about limitations. For some areas (including depression), there are systematic reviews cautioning that evidence quality varies and that some bodies of evidence are rated low due to methodological issues—meaning we should continue improving trial design and standards.

What’s happening in the brain during hypnosis?

One of the most exciting shifts in recent years is that hypnosis is now studied not just by outcomes (“does it work?”) but also by mechanisms (“how does it work?”).

1) Key brain networks involved

The review highlights evidence that hypnosis can modulate networks involved in:

  • Pain processing
  • Emotional regulation
  • Cognitive control

A repeatedly cited hub here is the anterior cingulate cortex (ACC)—a region deeply involved in how we experience pain and regulate emotion.

The review also discusses hypnosis-related modulation of the default mode network (DMN), which is strongly linked to self-referential thinking and rumination—particularly relevant for depression.

2) Pain modulation: changing the “pain matrix”

Pain is not only a signal from the body—it is also an experience shaped by attention, interpretation, emotion, and meaning. Neuroimaging findings described in the paper suggest hypnosis can alter activity in the brain’s distributed “pain matrix” (including ACC, insula, somatosensory regions, and others), supporting reductions in perceived pain and distress.

3) Timing matters: EEG evidence in anxiety

Hypnosis doesn’t only change what we feel; it appears to change how quickly the brain responds to emotionally relevant cues.

In social anxiety disorder, the review describes evidence that hypnotherapy reduced both early and late event-related potentials during face-processing tasks—signals that reflect rapid automatic processing and more sustained attention to emotionally salient stimuli. Those neural changes tracked with symptom improvements.

If you translate that into everyday language: hypnosis may help people become less “hooked” by threat signals—both in the first split-second and in the longer mental replay afterward.

Where hypnotherapy shows meaningful clinical impact

Let’s walk through the main application areas covered in the review.

Depression and mood disorders

Depression is one of the most studied areas in the paper, and the outcomes are compelling:

  • Meta-analytic evidence summarized in the review reports an effect size around 0.71 at the end of treatment and 0.52 at longest follow-up for depressive symptoms.
  • A notable non-inferiority trial described in the review found hypnotherapy was non-inferior to CBT in mild to moderate depression, with 73% remission after a median of 30 weeks—and benefits that persisted at 3.5-year follow-up.
  • There’s also evidence that combining CBT with hypnosis (CBTH) may improve some outcomes, potentially by enhancing engagement, expectancy, and consolidation of skills.

A key point: depression is often chronic and recurrent. Long-term maintenance is not a “nice to have”—it’s essential. This is why multi-year follow-up results are so meaningful.

Chronic pain and fibromyalgia

This is one of the strongest areas for hypnosis research.

The review describes a controlled trial where people with fibromyalgia received eight weekly one-hour hypnotherapy sessions and showed significant pain reductions at post-treatment and follow-up. Beyond pain, improvements extended to sleep, mood symptoms, catastrophizing, and quality of life—without reported adverse events.

It also highlights a study in which self-hypnosis practice supported benefits that persisted over months—an important theme: hypnotherapy often involves teaching skills people can continue using beyond the therapy room.

The review also takes a balanced view: in at least one comparison, Acceptance and Commitment Therapy (ACT) produced more stable reductions in some pain dimensions at follow-up for some patients—suggesting the “best” therapy can depend on the person, not only the diagnosis.

Anxiety disorders and PTSD

For anxiety, the paper highlights both symptom outcomes and measurable neurophysiological shifts.

  • In social anxiety disorder, six weekly hypnotherapy sessions reduced symptoms and altered EEG markers linked to threat-focused attention.
  • In military personnel experiencing anxiety and depression, cognitive behavioral hypnotherapy (CBH) showed stronger improvements than CBT in a quasi-experimental design.
  • For trauma-related symptoms, the review summarizes a network meta-analysis suggesting different hypnotic approaches may fit different targets: some approaches appear stronger for PTSD symptom reduction, while others may better support anxiety reduction and relationship outcomes.

If there’s one takeaway here, it’s this: hypnosis is not one monolithic technique. The modality is flexible—and the research increasingly supports matching the approach to the person and the symptom profile.

Surgical and procedural pain management

This is where hypnosis becomes especially relevant to modern healthcare systems—because it intersects with medication reduction and recovery outcomes.

The paper describes evidence that perioperative hypnosis reduced in-hospital opioid consumption in a randomized trial, with an “opioid-sparing” effect.

It also describes hypnosis helping protect against increases in pain catastrophizing post-surgery, a psychological factor linked to worse recovery trajectories.

The review also summarizes a large systematic review/meta-analysis of 70 RCTs (n = 6,078) on adjunctive hypnosis for clinical pain, finding small-to-medium additional analgesic effects depending on what hypnosis is combined with (usual care, education, medicines).

In short: even when hypnosis is not the only intervention, it can meaningfully improve the overall package of care.

Irritable bowel syndrome

IBS is a classic mind–body condition: stress and emotional dysregulation can intensify symptoms, and symptoms can intensify stress.

The review describes a three-arm randomized trial (72 adults with refractory IBS) comparing hypnotherapy, CBT, and control. Both hypnotherapy and CBT improved pain indices and cognitive emotion regulation, and benefits remained stable at six-month follow-up.

Hypnotherapy vs. CBT: competition, complement, or combination?

One of the most practical questions clinicians and patients ask is: Where does hypnotherapy fit relative to CBT?

The review suggests three answers can all be true, depending on the person and context:

  1. Comparable (for some conditions, like depression, hypnotherapy can be non-inferior to CBT).
  2. Complementary (hypnosis can enhance outcomes when added to usual care or other psychological approaches).
  3. Synergistic (combined approaches like CBTH may bring advantages by pairing structured skills with experiential depth).

Safety: an underrated part of the story

A major reason hypnotherapy deserves serious consideration is not only effectiveness—it’s safety.

Across the body of work reviewed, no significant adverse events were reported in connection with hypnotic interventions.

At the same time, the review emphasizes responsible practice:

  • Hypnotherapy should be delivered by trained, qualified practitioners
  • Proper screening, informed consent, and ethical practice matter
  • Potential contraindications may include active psychosis, severe dissociative disorders, or inability/unwillingness to provide informed consent

This is a core message: hypnosis is not “dangerous,” but like any therapeutic tool, it should be used competently.

What needs to happen next

The paper closes with a forward-looking roadmap—what the field needs to strengthen the evidence and improve adoption:

  • Larger, better-powered trials with strong controls and long-term follow-up
  • Standardized protocols to support comparability and training
  • Predictors of response and personalized approaches (because the same tool won’t fit everyone)
  • Deeper mechanistic research, including neurochemical and molecular pathways
  • Clarifying dose: number of sessions, frequency, and the role of self-hypnosis
  • Technology-assisted delivery: VR + hypnosis, smartphone support, telehealth expansion
  • Implementation barriers: training availability, misconceptions, insurance coverage, and the need for cost-effectiveness research

So what should readers take away?

If you only remember a few points, let them be these:

  • Hypnosis has moved into the realm of credible, evidence-based care for multiple mental and physical health conditions.
  • The strongest evidence clusters around pain, medical procedures, depression, anxiety/PTSD, and IBS.
  • Outcomes can be durable—sometimes sustained for months to years, including multi-year follow-up in depression research.
  • The “how” is increasingly visible: hypnosis appears to modulate brain networks linked to pain, attention, and emotion regulation.
  • Safety looks strong in the reviewed evidence, especially compared with many pharmacological pathways—when delivered ethically and appropriately.

A gentle note (and an invitation)

This post summarizes research for education and reflection—it’s not medical advice. If you’re considering hypnotherapy for a specific condition, the safest path is to consult a qualified healthcare professional and work with a trained hypnotherapist who practices ethically and collaboratively.